|
Report Date : |
11.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
BRUKER BIOSPIN INTERNATIONAL AG |
|
|
|
|
Registered Office : |
Aegeristrasse 52, Postfach 351, 6301
Zug/ZG |
|
|
|
|
Country : |
Switzerland |
|
|
|
|
Date of Incorporation : |
11.03.1987 |
|
|
|
|
Com. Reg. No.: |
170.3.012.524-6 / 466763 |
|
|
|
|
Legal Form : |
Company limited by shares |
|
|
|
|
Line of Business : |
The
business activities includes the marketing and distribution of scientific
equipment for the analytical instrumentation and research |
|
|
|
|
No. of Employees : |
10-19 employées |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Switzerland - ECONOMIC OVERVIEW
Switzerland is a peaceful, prosperous, and modern market economy with low unemployment, a highly skilled labor force, and a per capita GDP among the highest in the world. Switzerland's economy benefits from a highly developed service sector, led by financial services, and a manufacturing industry that specializes in high-technology, knowledge-based production. Its economic and political stability, transparent legal system, exceptional infrastructure, efficient capital markets, and low corporate tax rates also make Switzerland one of the world's most competitive economies. The Swiss have brought their economic practices largely into conformity with the EU's, to enhance their international competitiveness, but some trade protectionism remains, particularly for its small agricultural sector. The fate of the Swiss economy is tightly linked to that of its neighbors in the euro zone, which purchases half of all Swiss exports. The global financial crisis of 2008 and resulting economic downturn in 2009 stalled export demand and put Switzerland in a recession. The Swiss National Bank (SNB) during this period effectively implemented a zero-interest rate policy to boost the economy as well as prevent appreciation of the franc, and Switzerland's economy recovered in 2010 with 2.7% growth. The sovereign debt crises currently unfolding in neighboring euro-zone countries pose a significant risk to Switzerland's financial stability and are driving up demand for the Swiss franc by investors seeking a safehaven currency. The independent SNB has upheld its zero-interest rate policy and conducted major market interventions to prevent further appreciation of the Swiss franc, but parliamentarians have urged it to do more to weaken the currency. The franc's strength has made Swiss exports less competitive and weakened the country's growth outlook; GDP growth fell to 2.1% in 2011. Switzerland has also come under increasing pressure from individual neighboring countries, the EU, the US, and international institutions to reform its banking secrecy laws. Consequently, the government agreed to conform to OECD regulations on administrative assistance in tax matters, including tax evasion. The government has renegotiated its double taxation agreements with numerous countries, including the US, to incorporate the OECD standard, and in 2011 it reached deals with Germany and the UK to resolve outstanding issues, particularly the possibility of imposing taxes on bank deposits held by foreigners. These steps will have a lasting impact on Switzerland's long history of bank secrecy.
|
Source
: CIA |
Bruker BioSpin International AG
Aegeristrasse 52
Postfach 351
6301 Zug/ZG
Switzerland/CH
Telephone: 041
7104433
Fax: 041
7104570
Web
site: http://www.bruker.com
E-mail: sales@bruker-biospin.ch
VAT-No.: CHE103881088
Established: 1987
Line of Business: Consumer goods wholesale
Industry Division: Wholesale trade
Industry-code (NACE): 4646 Wholesale of
pharmaceutical goods
4669 Wholesale of other machinery and equipment
Import/Export: Import,
Export
Banks: unknown
Coverage: Company
Figures: estimated
Employees: 10-19
The
business activities includes the marketing and distribution of scientific
equipment for the analytical instrumentation and research.
Information on property
ownership was not available.
Company No: 170.3.012.524-6
/ 466763
Legal form: Company
limited by shares
Registration: 11.03.1987
Legal
status: active
Responsible
Register: Handelsregister des Kantons
Zug
History: Date
of Incorporation Statutes: 06.03.1987
Date
of Statutes: 13.02.2008
Date
of Statutes: 20.12.2007
Date
of Statutes: 27.04.2005
Date
of Statutes: 07.12.2001
Date
of Statutes: 06.09.1999
Date
of Statutes: 20.11.1996
Entry Deleted Name
11.12.2001 Bruker
BioSpin International AG
11.12.2001 Bruker
BioSpin International Ltd (Name translated)
11.12.2001 Bruker
BioSpin International SA (Name translated)
14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft AG
14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft SA
(Name translated)
14.09.1999 Bruker-Spectrospin Vertriebsgemeinschaft Corp.
(Name translated)
14.09.1999 11.12.2001 Bruker International AG
14.09.1999 11.12.2001 Bruker International SA (Name translated)
14.09.1999 11.12.2001 Bruker International Ltd (Name translated)
Entry Deleted Legal domicile
active Zug,
Switzerland
Entry Deleted Address
10.04.2007 Aegeristrasse
52, 6300 Zug/ZG, Switzerland/CH
10.04.2007 Gotthardstrasse 18, 6300 Zug/ZG,
Switzerland/CH
Entry Deleted Capital
11.05.2005 Share
Capital CHF 8'500'000, paidup CHF 8'500'000
Entry Deleted Capital Structure
11.05.2005 8'500
Registered shares of CHF 1'000.--
Entry Deleted Activity (original Language)
21.02.2008 Weltweiter
An- und Verkauf, Import und Export, Lagerung und Transport von sowie Handel mit
Produkten aller Art, insbesondere wissenschaftlichen Geräten für die
analytische Messtechnik innerhalb der Bruker Gruppe; kann Finanzierungen für
eigene oder fremde Rechnung vornehmen sowie Sicherungsgeschäfte,
einschliesslich Garantien, Pfandbestellungen, Globalzessionen,
Sicherungsübereignungen und Schadloshaltungserklärungen für verbundene
Unternehmen und Dritte eingehen, auch wenn diese in deren ausschliesslichem
Interesse liegen, Patente, Lizenzen und Herstellungsverfahren erwerben,
entwickeln, verwalten und verwerten, mit Waren aller Art handeln, Grundstücke
erwerben, halten und veräussern, Tochtergesellschaften errichten sowie sich an
anderen Unternehmen beteiligen.
Entry Deleted Remarks (original Language)
active Publishing
authority: SHAB.
Title Name
President Dr.
Christoph Straub-Schmidli, Origin: Basel, Herzogenbuchsee, Switzerland,
Residential address: Zug, Switzerland, joint signature of two
Chief
Executive Dr.
Werner E. Maas, Origin: Netherlands, Residential address: Merrimac , United
States of America, joint signature of two, Registered since: 08.07.2010
Director Roger
Deutsch, Origin: Märstetten, Switzerland, Residential address: Uetikon am See,
Switzerland, joint signature of two, Registered since: 15.04.2005
Title Name
Director Roger
Deutsch, Origin: Märstetten, Switzerland, Residential address: Uetikon am See,
Switzerland, joint signature of two, Registered since: 15.04.2005
Vice-Director Dr. Kurt Schenker,
Origin: Däniken, Switzerland, Residential address: Maur, Switzerland, joint
signature of two, Registered since: 08.07.2010
Vice-Director Urs Widmer,
Origin: Lindau, Switzerland, Residential address: Neftenbach, Switzerland,
joint signature of two, Registered since: 08.07.2010
Member
with procuration Peter
Kistler, Origin: Reichenburg, Switzerland, Residential address: Jona,
Switzerland, joint power of attorney of two, Registered since: 08.07.2010
Member
with procuration Dr. Peter
Scherer, Origin: Killwangen, Switzerland, Residential address: Dübendorf,
Switzerland, joint power of attorney of two, Registered since: 13.07.2011
Title Name
Auditor Ernst
& Young AG, Residential address: Zürich, Switzerland, Id:
CH-020.9.001.069.0, Registered since: 06.10.2008
Name: Bruker Corporation
City/Country: Billerica/Massachusetts, United
States of America/US
No.
of Owner/-s: 1
Owner: The company is foreign
owned.
Class: 100%
Name: Bruker Invest AG
City/Country: Zug/ZG, Switzerland/CH
Interest: 100.00% voting right,
100.00% capital interest
Name: Bruker BioSpin AG
City/Country: Fällanden/ZH, Switzerland/CH
Class: 100%
Name: Bruker (Beijing)
Technologies & services Co. Ltd.
City/Country: Beijing, China/CN
Interest: 100.00% voting right,
100.00% capital interest
Class: 100%
Name: Bruker BioSpin Pte
Ltd.
City/Country: Singapore, Singapore/SG
Interest: 100.00% voting right,
100.00% capital interest
Class: 100%
Name: BRUKER INDIA
SCIENTIFIC PRIVATE LIMITED
City/Country: MUMBAI/Maharashtra, India/IN
Interest: 100.00% voting right,
100.00% capital interest
Class: 100%
Name: Bruker (Malaysia) SDN
BHD
City/Country: Petaling Jaya/Selangor,
Malaysia/MY
Interest: 100.00% voting right, 100.00%
capital interest
Class: 100%
Name: Bruker Russia LLC
City/Country: Moscow, Russia/RU
Interest: 100.00% voting right,
100.00% capital interest
An updated legal action check is only available against proof of
interest. e.g. a copy of an enquiry letter, and order or invoice relating to
the subject company.
Financial
Statements: The company does not
disclose any financial statements. Third parties are not permitted any insight
into the financial affairs. It is therefore difficult to make a proper
assessment of the actual situation.
Financial
Situation: The financial situation
is in order.
Payment
experiences: There are no objections
regarding the payment of financial obligations.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.40 |
|
UK Pound |
1 |
Rs.81.57 |
|
Euro |
1 |
Rs.71.24 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.